A case of fatal Pemphigus Vulgaris in association with beta interferon and interleukin‐2 therapy

Cancer

Volumn 63, Issue 10, 1989, Pages 2005-2007

  Ramseur, William L ^a   Ii, Frederick Richards ^a   Duggan, David B ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; INTERLEUKIN 2;

AUTOIMMUNITY; CASE REPORT; FATALITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTOMA; MALE; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; SIDE EFFECT;

CASE REPORT; HUMAN; INTERFERON TYPE I; INTERLEUKIN-2; LYMPHOMA, SMALL-CELL; MALE; MIDDLE AGE; PEMPHIGUS;

EID: 0024513347     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19890515)63:10<2005::AID-CNCR2820631023>3.0.CO;2-P     Document Type: Article

References (31)

1. The immunopathology of pemphigus vulgaris: Recent advances
2. Pemphigus vulgaris and lymphoma in a patient with scleroderma
3. Coexistence of pemphigus foliaceus and mycosis fungoides
4. Lymphomatoid granulomatosis after immunosuppresion for pemphigus
5. Pemphigus vulgaris and internal malignancy
6. The association of pemphigus with thymoma or malignancy: A critical review
7. Fatal pemphigus vulgaris in a patient taking Piroxicam
8. Case 26‐1980: Pemphigus vulgaris after hyposensitization injections
9. Deficiency of interleukin‐2 production and interleukin‐2 receptor expression on peripheral blood leukocytes after phytohemagglutinin stimulation in pemphigus
10. Interleukin‐2 deficiency in pemphigus vulgaris
11. Normalization of defective interleukin‐1 and interleukin‐2 production in patients with pemphigus vulgaris following crysotherapy
12. Immune thrombocytopenia following alpha interferon therapy in patients with cancer
13. Thyroid autoimmunity in patients on long term therapy with leukocyte‐derived interferon
14. Alpha interferon and immune hemolytic anemia
15. Cutaneous vasculitis associated with interferon
16. Nephrotic syndrome during treatment with interferon
17. Clinical toxicity of interferons in cancer patients: A review
18. Acute interstitial nephritis with the nephrotic syndrome following recombinant leucocyte A interferon therapy for mycosis fungoid
19. Clinical effects and toxicity of interleukin‐2 in patients with cancer
20. Dermatologic changes associated with interleukin‐2 administration
21. Erythema nodosum in a patient with renal cell carcinoma treated with interleukin‐2 and lymphokine‐activated killer cells (letter)
22. Effect of recombinant IL‐2 and gamma IFN on proliferation and differentiation of human B‐cells
23. Detection and functional studies of p60‐65 (TAC antigen) on activated human B cells
24. Effects of bacteria‐produced human alpha, beta, and gamma interferons on in vitro immune function
25. Interferon treatment of NZB mice: Accelerated progression of autoimmune disease
26. Progressive glomerulonephritis in mice treated with interferon preparations at birth
27. Extraction of pemphigus antibodies from a lymphoid neoplasm and its possible relationship to pemphigus vulgaris
28. Bullous dermatosis and myeloma: Monoclonal anticytoplasmic antibody activity